OBJECTIVE: To describe study design, methods and baseline findings of a behavioural intervention alone and in combination with improved management of sexually transmitted diseases (STDs) aimed at reducing HIV incidence and other STDs. DESIGN: A three-arm community randomized controlled trial (RCT) of 18 rural communities (approximately 96 000 adults) in SW Uganda. A standardized behavioural intervention was implemented in 12 communities (arms A and B) through community-based education, meetings and information leaflets. Six of these communities in addition received improved STD management through government and private health units (arm B). Arm C communities received routine government health services. Impact assessment was through three questionnaire and serological surveys of 750-1000 adults in each community at 18-24-month intervals. The primary outcome measure was HIV incidence and secondary measures were syphilis and herpes simplex virus type 2 incidence, prevalence of Neisseria gonorrhoea and Chlamydia trachomatis and sexual behaviour changes. RESULTS:Approximately 15 000 adults (72% of eligible population) were enrolled at baseline. HIV baseline prevalence rates were 9-10% in all arms and demographic and behavioural characteristics and STD prevalence were also similar. In intervention communities, there were 391 995 attendance at 81 502 activities (6.1 per target adult), 164 063 leaflets distributed (2.6 per person) and 1 586 270 condoms (16.5 condoms per adult). In the STD communities a total of 12 239 STD cases (65% women) were seen over a 5-year period (7.7 per 100 adults/year). CONCLUSION: This is the first community RCT of its type with a behavioural component. There is fair baseline comparability between study arms and process data suggest that interventions were adequately implemented.
RCT Entities:
OBJECTIVE: To describe study design, methods and baseline findings of a behavioural intervention alone and in combination with improved management of sexually transmitted diseases (STDs) aimed at reducing HIV incidence and other STDs. DESIGN: A three-arm community randomized controlled trial (RCT) of 18 rural communities (approximately 96 000 adults) in SW Uganda. A standardized behavioural intervention was implemented in 12 communities (arms A and B) through community-based education, meetings and information leaflets. Six of these communities in addition received improved STD management through government and private health units (arm B). Arm C communities received routine government health services. Impact assessment was through three questionnaire and serological surveys of 750-1000 adults in each community at 18-24-month intervals. The primary outcome measure was HIV incidence and secondary measures were syphilis and herpes simplex virus type 2 incidence, prevalence of Neisseria gonorrhoea and Chlamydia trachomatis and sexual behaviour changes. RESULTS: Approximately 15 000 adults (72% of eligible population) were enrolled at baseline. HIV baseline prevalence rates were 9-10% in all arms and demographic and behavioural characteristics and STD prevalence were also similar. In intervention communities, there were 391 995 attendance at 81 502 activities (6.1 per target adult), 164 063 leaflets distributed (2.6 per person) and 1 586 270 condoms (16.5 condoms per adult). In the STD communities a total of 12 239 STD cases (65% women) were seen over a 5-year period (7.7 per 100 adults/year). CONCLUSION: This is the first community RCT of its type with a behavioural component. There is fair baseline comparability between study arms and process data suggest that interventions were adequately implemented.
Authors: Diego F Cuadros; Philip H Crowley; Ben Augustine; Sarah L Stewart; Gisela García-Ramos Journal: BMC Infect Dis Date: 2011-08-11 Impact factor: 3.090
Authors: Eugene Ruzagira; Symon Wandiembe; Andrew Abaasa; Jonathan Levin; Agnes Bwanika; Ubaldo Bahemuka; Matthew A Price; Anatoli Kamali Journal: PLoS One Date: 2011-06-03 Impact factor: 3.240
Authors: Noah Kiwanuka; Ali Ssetaala; Juliet Mpendo; Matthias Wambuzi; Annet Nanvubya; Simon Sigirenda; Annet Nalutaaya; Paul Kato; Leslie Nielsen; Pontiano Kaleebu; Josephine Nalusiba; Nelson K Sewankambo Journal: J Int AIDS Soc Date: 2013-07-22 Impact factor: 5.396
Authors: Anatoli Kamali; Matt A Price; Shabir Lakhi; Etienne Karita; Mubiana Inambao; Eduard J Sanders; Omu Anzala; Mary H Latka; Linda-Gail Bekker; Pontiano Kaleebu; Gershim Asiki; Ali Ssetaala; Eugene Ruzagira; Susan Allen; Paul Farmer; Eric Hunter; Gaudensia Mutua; Heeran Makkan; Amanda Tichacek; Ilene K Brill; Pat Fast; Gwynn Stevens; Paramesh Chetty; Pauli N Amornkul; Jill Gilmour Journal: PLoS One Date: 2015-01-20 Impact factor: 3.240
Authors: David Guwatudde; Fred Wabwire-Mangen; Leigh Anne Eller; Michael Eller; Francine McCutchan; Hannah Kibuuka; Monica Millard; Nelson Sewankambo; David Serwadda; Nelson Michael; Merlin Robb Journal: PLoS One Date: 2009-01-07 Impact factor: 3.240
Authors: Chioma Oringanje; Martin M Meremikwu; Hokehe Eko; Ekpereonne Esu; Anne Meremikwu; John E Ehiri Journal: Cochrane Database Syst Rev Date: 2016-02-03
Authors: Richard G White; Kate K Orroth; Judith R Glynn; Esther E Freeman; Roel Bakker; J Dik F Habbema; Fern Terris-Prestholt; Lilani Kumaranayake; Anne Buvé; Richard J Hayes Journal: J Acquir Immune Defic Syndr Date: 2008-03-01 Impact factor: 3.731
Authors: Noah Kiwanuka; Juliet Mpendo; Annet Nalutaaya; Matthias Wambuzi; Annet Nanvubya; Paul K Kitandwe; Enoch Muyanja; Julius Ssempiira; Apolo Balyegisawa; Ali Ssetaala Journal: BMC Public Health Date: 2014-09-22 Impact factor: 3.295